Repligen | RGEN - EPS Earnings Per Share


Repligen reported $0.53 in EPS Earnings Per Share for its fiscal quarter ending in September of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 0.53 0.47 0.46 Oct/27
FY2026Q2 Jun/2026 0.54 0.45 0.37 Jul/28
FY2026Q1 Mar/2026 0.48 0.39 0.39 May/05
FY2025Q4 Dec/2025 0.49 0.44 0.44 Feb/24
FY2025Q3 Sep/2025 0.46 0.42 0.43 Oct/28




Eps Change Date
Agilent USD 1.52 0.08 Jun/2026
Align Technology USD 2.8 0.16 Sep/2026
Bio Techne USD 0.52 0.01 Jun/2026
BioMarin Pharmaceutical USD 0.23 0.97 Sep/2026
Bristol-Myers Squibb USD 1.35 0.69 Sep/2026
Bruker USD 0.56 0.07 Sep/2026
Charles River Laboratories USD 3.09 0.07 Sep/2026
Danaher USD 1.75 0.19 Sep/2026
Dentsply International USD 0.29 0.23 Sep/2026
General Electric Aerospace USD 2.17 0.16 Sep/2026
Henry Schein USD 1.56 0.29 Sep/2026
Illumina USD 1.44 0.13 Sep/2026
IQVIA Holdings USD 3.34 0.19 Sep/2026
Mettler Toledo International USD 12.57 1.11 Sep/2026
Myriad Genetics USD -0.25 0.16 Jun/2026
OraSure Technologies USD -0.18 0 Dec/2025
Pacific Biosciences Of California USD -0.17 0.12 Dec/2025
Pfizer USD 0.87 0.1 Sep/2026
Repligen USD 0.53 0.01 Sep/2026
Revvity USD 1.37 0.04 Sep/2026
Standard Biotools USD -0.07 0.4 Jun/2026
Thermo Fisher Scientific USD 5.18 0.86 Sep/2026
Waters USD 4.1 1.05 Sep/2026
West Pharmaceutical Services USD 2.66 0.29 Sep/2026